Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF – Get Free Report) shares fell 6.7% on Thursday . The company traded as low as $13.77 and last traded at $14.97. 1,259 shares changed hands during mid-day trading, a decline of 47% from the average session volume of 2,373 shares. The stock had previously closed at $16.05.
Kyowa Kirin Trading Down 6.7 %
The firm has a fifty day simple moving average of $16.87 and a 200-day simple moving average of $18.36.
Kyowa Kirin Company Profile
Kyowa Kirin Co, Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally. Its products include ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.
Read More
- Five stocks we like better than Kyowa Kirin
- 3 Tickers Leading a Meme Stock Revival
- Micron Stock Under $100: Seize the AI-Driven Upside
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- P/E Ratio Calculation: How to Assess Stocks
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Kyowa Kirin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kyowa Kirin and related companies with MarketBeat.com's FREE daily email newsletter.
